Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µCT study.

Osteonecrosis of the jaw, in association with bisphosphonates (BRONJ) used for treating osteoporosis or cancer, is a severe and most often irreversible side effect whose underlying pathophysiological mechanisms remain largely unknown. Osteocytes are involved in bone remodeling and mineralization whe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bernhard Hesse, Max Langer, Peter Varga, Alexandra Pacureanu, Pei Dong, Susanne Schrof, Nils Männicke, Heikki Suhonen, Cecile Olivier, Peter Maurer, Galateia J Kazakia, Kay Raum, Francoise Peyrin
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/95b5d9f4dd4b46e7bad1dc26f90fd63a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:95b5d9f4dd4b46e7bad1dc26f90fd63a
record_format dspace
spelling oai:doaj.org-article:95b5d9f4dd4b46e7bad1dc26f90fd63a2021-11-18T08:31:37ZAlterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µCT study.1932-620310.1371/journal.pone.0088481https://doaj.org/article/95b5d9f4dd4b46e7bad1dc26f90fd63a2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586331/?tool=EBIhttps://doaj.org/toc/1932-6203Osteonecrosis of the jaw, in association with bisphosphonates (BRONJ) used for treating osteoporosis or cancer, is a severe and most often irreversible side effect whose underlying pathophysiological mechanisms remain largely unknown. Osteocytes are involved in bone remodeling and mineralization where they orchestrate the delicate equilibrium between osteoclast and osteoblast activity and through the active process called osteocytic osteolysis. Here, we hypothesized that (i) changes of the mineralized tissue matrix play a substantial role in the pathogenesis of BRONJ, and (ii) the osteocyte lacunar morphology is altered in BRONJ. Synchrotron µCT with phase contrast is an appropriate tool for assessing both the 3D morphology of the osteocyte lacunae and the bone matrix mass density. Here, we used this technique to investigate the mass density distribution and 3D osteocyte lacunar properties at the sub-micrometer scale in human bone samples from the jaw, femur and tibia. First, we compared healthy human jaw bone to human tibia and femur in order to assess the specific differences and address potential explanations of why the jaw bone is exclusively targeted by the necrosis as a side effect of BP treatment. Second, we investigated the differences between BRONJ and control jaw bone samples to detect potential differences which could aid an improved understanding of the course of BRONJ. We found that the apparent mass density of jaw bone was significantly smaller compared to that of tibia, consistent with a higher bone turnover in the jaw bone. The variance of the lacunar volume distribution was significantly different depending on the anatomical site. The comparison between BRONJ and control jaw specimens revealed no significant increase in mineralization after BP. We found a significant decrease in osteocyte-lacunar density in the BRONJ group compared to the control jaw. Interestingly, the osteocyte-lacunar volume distribution was not altered after BP treatment.Bernhard HesseMax LangerPeter VargaAlexandra PacureanuPei DongSusanne SchrofNils MännickeHeikki SuhonenCecile OlivierPeter MaurerGalateia J KazakiaKay RaumFrancoise PeyrinPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 2, p e88481 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Bernhard Hesse
Max Langer
Peter Varga
Alexandra Pacureanu
Pei Dong
Susanne Schrof
Nils Männicke
Heikki Suhonen
Cecile Olivier
Peter Maurer
Galateia J Kazakia
Kay Raum
Francoise Peyrin
Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µCT study.
description Osteonecrosis of the jaw, in association with bisphosphonates (BRONJ) used for treating osteoporosis or cancer, is a severe and most often irreversible side effect whose underlying pathophysiological mechanisms remain largely unknown. Osteocytes are involved in bone remodeling and mineralization where they orchestrate the delicate equilibrium between osteoclast and osteoblast activity and through the active process called osteocytic osteolysis. Here, we hypothesized that (i) changes of the mineralized tissue matrix play a substantial role in the pathogenesis of BRONJ, and (ii) the osteocyte lacunar morphology is altered in BRONJ. Synchrotron µCT with phase contrast is an appropriate tool for assessing both the 3D morphology of the osteocyte lacunae and the bone matrix mass density. Here, we used this technique to investigate the mass density distribution and 3D osteocyte lacunar properties at the sub-micrometer scale in human bone samples from the jaw, femur and tibia. First, we compared healthy human jaw bone to human tibia and femur in order to assess the specific differences and address potential explanations of why the jaw bone is exclusively targeted by the necrosis as a side effect of BP treatment. Second, we investigated the differences between BRONJ and control jaw bone samples to detect potential differences which could aid an improved understanding of the course of BRONJ. We found that the apparent mass density of jaw bone was significantly smaller compared to that of tibia, consistent with a higher bone turnover in the jaw bone. The variance of the lacunar volume distribution was significantly different depending on the anatomical site. The comparison between BRONJ and control jaw specimens revealed no significant increase in mineralization after BP. We found a significant decrease in osteocyte-lacunar density in the BRONJ group compared to the control jaw. Interestingly, the osteocyte-lacunar volume distribution was not altered after BP treatment.
format article
author Bernhard Hesse
Max Langer
Peter Varga
Alexandra Pacureanu
Pei Dong
Susanne Schrof
Nils Männicke
Heikki Suhonen
Cecile Olivier
Peter Maurer
Galateia J Kazakia
Kay Raum
Francoise Peyrin
author_facet Bernhard Hesse
Max Langer
Peter Varga
Alexandra Pacureanu
Pei Dong
Susanne Schrof
Nils Männicke
Heikki Suhonen
Cecile Olivier
Peter Maurer
Galateia J Kazakia
Kay Raum
Francoise Peyrin
author_sort Bernhard Hesse
title Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µCT study.
title_short Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µCT study.
title_full Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µCT study.
title_fullStr Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µCT study.
title_full_unstemmed Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µCT study.
title_sort alterations of mass density and 3d osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron µct study.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/95b5d9f4dd4b46e7bad1dc26f90fd63a
work_keys_str_mv AT bernhardhesse alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT maxlanger alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT petervarga alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT alexandrapacureanu alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT peidong alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT susanneschrof alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT nilsmannicke alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT heikkisuhonen alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT cecileolivier alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT petermaurer alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT galateiajkazakia alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT kayraum alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
AT francoisepeyrin alterationsofmassdensityand3dosteocytelacunarpropertiesinbisphosphonaterelatedosteonecrotichumanjawboneasynchrotronμctstudy
_version_ 1718421697479049216